X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (625) 625
Patent (30) 30
Conference Proceeding (20) 20
Publication (18) 18
Book Review (4) 4
Report (4) 4
Book / eBook (3) 3
Book Chapter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (179) 179
index medicus (148) 148
oncology (144) 144
hypoxia (105) 105
radiology, nuclear medicine & medical imaging (104) 104
radiotherapy (100) 100
hematology, oncology and palliative medicine (94) 94
female (85) 85
cancer (84) 84
animals (81) 81
tumors (65) 65
mice (64) 64
male (59) 59
middle aged (54) 54
aged (53) 53
squamous-cell carcinoma (51) 51
prognosis (50) 50
cell line, tumor (43) 43
immunohistochemistry (39) 39
adult (36) 36
radiation (36) 36
positron-emission-tomography (35) 35
neck-cancer (34) 34
chemotherapy (32) 32
cell hypoxia (31) 31
chemistry (31) 31
carcinoma (30) 30
metallurgy (30) 30
expression (29) 29
mice, inbred balb c (29) 29
mice, nude (29) 29
radiation-therapy (29) 29
aged, 80 and over (28) 28
care and treatment (28) 28
compositions based thereon (28) 28
head and neck cancer (28) 28
lung cancer, non-small cell (28) 28
organic macromolecular compounds (28) 28
their preparation or chemical working-up (28) 28
positron-emission tomography (27) 27
analysis (26) 26
carcinoma, squamous cell - pathology (26) 26
lung cancer (26) 26
treatment outcome (26) 26
head and neck neoplasms - pathology (25) 25
research (25) 25
carcinoma, squamous cell - metabolism (24) 24
compositions of macromolecular compounds (24) 24
lung neoplasms - pathology (23) 23
pet (23) 23
prognostic value (23) 23
head and neck neoplasms - metabolism (22) 22
metastasis (22) 22
proliferation (22) 22
squamous cell carcinoma (22) 22
head (21) 21
survival (21) 21
cetuximab (20) 20
lung neoplasms - radiotherapy (20) 20
proteins (20) 20
egfr (18) 18
head and neck neoplasms - diagnostic imaging (18) 18
neoplasm transplantation (18) 18
non-small cell lung cancer (18) 18
tumor hypoxia (18) 18
carcinoma, non-small-cell lung - pathology (17) 17
cells (17) 17
growth-factor receptor (17) 17
positron-emission tomography - methods (17) 17
radiation therapy (17) 17
radiopharmaceuticals (17) 17
accelerated radiotherapy (16) 16
breast-cancer (16) 16
carcinoma, non-small-cell lung - radiotherapy (16) 16
cell lung-cancer (16) 16
gene expression regulation, neoplastic (16) 16
inhibition (16) 16
lung-cancer (16) 16
nuclear radiation (16) 16
pet imaging (16) 16
therapy (16) 16
transplantation, heterologous (16) 16
amino acid sequence (15) 15
biomarkers (15) 15
biomarkers, tumor - metabolism (15) 15
breast cancer (15) 15
cancer research (15) 15
carcinoma, squamous cell - diagnostic imaging (15) 15
lung neoplasms - diagnostic imaging (15) 15
multidisciplinary sciences (15) 15
nuclear medicine (15) 15
research article (15) 15
time factors (15) 15
use of inorganic or non-macromolecular organic substances ascompounding ingredients (15) 15
xenograft model antitumor assays (15) 15
carbonic anhydrase ix (14) 14
f-18-fdg pet (14) 14
fluorodeoxyglucose f18 (14) 14
head and neck neoplasms - radiotherapy (14) 14
neoplasms - metabolism (14) 14
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2012, Volume 30, Issue 15, pp. 1777 - 1783
Journal Article
Radiation Research, ISSN 0033-7587, 2013, Volume 180, Issue 4, pp. 414 - 421
Epidermal growth factor receptor (EGFR) inhibition using cetuximab improves the efficacy of radiotherapy in only a subgroup of head and neck squamous cell... 
CANCER-CELLS | NUCLEAR IMPORT | STRAND BREAK REPAIR | GROWTH-FACTOR-RECEPTOR | RADIATION ONCOLOGY | TO-MESENCHYMAL TRANSITION | BIOPHYSICS | BIOLOGY | SQUAMOUS-CELL CARCINOMA | HOMOLOGOUS RECOMBINATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | K-RAS STATUS | CONCURRENT CETUXIMAB | Cell Hypoxia - radiation effects | Drug Resistance, Neoplasm - radiation effects | Apoptosis - drug effects | Apoptosis - radiation effects | Humans | DNA Repair - radiation effects | Intracellular Signaling Peptides and Proteins - metabolism | Phosphoproteins - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Cetuximab | Cell Hypoxia - drug effects | DNA Repair - drug effects | Antibodies, Monoclonal, Humanized - therapeutic use | Head and Neck Neoplasms - drug therapy | Combined Modality Therapy | Head and Neck Neoplasms - pathology | Xenograft Model Antitumor Assays | Head and Neck Neoplasms - radiotherapy | Animals | Mitogen-Activated Protein Kinase 3 - metabolism | Protein Kinase Inhibitors - therapeutic use | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Head and Neck Neoplasms - genetics | Mice | Mice, Inbred BALB C | Protein Kinase Inhibitors - pharmacology | DNA Damage | Tumor Suppressor p53-Binding Protein 1 | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism
Journal Article
BMC Cancer, ISSN 1471-2407, 2012, Volume 12, Issue 1, pp. 463 - 463
BACKGROUND: Only a minority of cancer patients benefits from the combination of EGFR-inhibition and radiotherapy in head and neck squamous cell carcinoma... 
Head and neck cancer | Hypoxia | pAKT | Tumor microenvironment | EGFR | SENSITIVITY | RADIATION-THERAPY | CETUXIMAB | ONCOLOGY | PATHWAY | GROWTH | SQUAMOUS-CELL CARCINOMA | RESISTANCE | RADIOTHERAPY | HUMAN CANCER | Heterocyclic Compounds, 3-Ring - pharmacology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Receptor, ErbB-2 - metabolism | Head and Neck Neoplasms - metabolism | Cell Hypoxia | Receptor, Epidermal Growth Factor - metabolism | Receptor, ErbB-2 - antagonists & inhibitors | Signal Transduction - radiation effects | Proto-Oncogene Proteins c-akt - metabolism | Tumor Microenvironment - drug effects | Cell Survival - drug effects | Nitroimidazoles - pharmacology | Radiation-Sensitizing Agents - pharmacology | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Combined Modality Therapy | Cell Survival - radiation effects | Blotting, Western | Head and Neck Neoplasms - pathology | Tumor Microenvironment - radiation effects | Xenograft Model Antitumor Assays | Animals | Signal Transduction - drug effects | Mice, Nude | Fluorescent Antibody Technique | Radiotherapy - methods | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Mice, Inbred BALB C | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Care and treatment | Physiological aspects | Research | Radiotherapy | Protein kinases | Health aspects | Proteins | Squamous cell carcinoma | Analysis | Tumors
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 05/2017, Volume 123, pp. S279 - S279
Journal Article
Scientific Reports, ISSN 2045-2322, 2015, Volume 5, Issue 1, p. 13087
Radiomics extracts and mines large number of medical imaging features quantifying tumor phenotypic characteristics. Highly accurate and reliable... 
CELL LUNG-CANCER | SURVIVAL | GLIOBLASTOMA | INFORMATION | MULTIDISCIPLINARY SCIENCES | CLASSIFICATION | DOCTORS | PHYSICIANS | CHEMOTHERAPY | PREDICTION | FEATURES | Learning | Learning algorithms | Teaching methods | Computed tomography | Invasiveness | Lung cancer | Classification | Biomarkers | Data processing
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 03/2013, Volume 110, Issue 12, pp. 4622 - 4627
Journal Article
Journal Article
by Karavana, V and Smith, I and Kanellis, G and Sigala, I and Kinsella, T and Zakynthinos, S and Liu, L and Chen, J and Zhang, X and Liu, A and Guo, F and Liu, S and Yang, Y and Qiu, H and Grimaldi, D. G and Kaya, E and Acicbe, O and Kayaalp, I and Asar, S and Dogan, M and Eren, G and Hergunsel, O and Pavelescu, D and Grintescu, I and Mirea, L and Guanziroli, M and Gotti, M and Marino, A and Cressoni, M and Vergani, G and Chiurazzi, C and Chiumello, D and Gattinoni, L and Spano, S and Massaro, F and Moustakas, A and Johansson, S and Larsson, A and Perchiazzi, G and Zhang, X. W and Guo, F. M and Chen, J. X and Xue, M and Qiu, H. B and Yang, L and Fister, M and Knafelj, R and Suzer, M. A and Kavlak, M. E and Atalan, H. K and Gucyetmez, B and Cakar, N and Weller, D and Grootendorst, A. F and Dijkstra, A and Kuijper, T. M and Cleffken, B. I and Regli, A and De Keulenaer, B and Van Heerden, P and Hadfield, D and Hopkins, P. A and Penhaligon, B and Reid, F and Hart, N and Rafferty, G. F and Grasselli, G and Mauri, T and Lazzeri, M and Carlesso, E and Cambiaghi, B and Eronia, N and Maffezzini, E and Bronco, A and Abbruzzese, C and Rossi, N and Foti, G and Bellani, G and Pesenti, A and Bassi, G. Li and Panigada, M and Ranzani, O and Kolobow, T and Zanella, A and Berra, L and Parrini, V and Kandil, H and Salati, G and Livigni, S and Amatu, A and Girardis, M and Barbagallo, M and Moise, G and Mercurio, G and Costa, A and Vezzani, A and Lindau, S and Babel, J and Cavana, M and Torres, A and ... and SR The SRLF Trial Group
Critical Care, ISSN 1364-8535, 03/2017, Volume 21, Issue S1
Journal Article
Journal Article